Vertex Pharmaceuticals Receives FDA Approval For Combo Cystic Fibrosis Drug

The FDA has approved Vertex's Orkambi Cystic Fibrosis drug for patients age 12 and older
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.